Phase 1 — Early testing in a small group of people (usually 20–80) to evaluate safety, determine safe dosage, and identify side effects.
Trial locations(21 sites)
United States
Crinetics Study Site, Duarte, California Crinetics Study Site, Newport Beach, California Crinetics Study Site, Orange, California Crinetics Study Site, San Francisco, California Crinetics Study Site, Denver, Colorado Crinetics Study Site, New Haven, Connecticut Crinetics Study Site, Atlanta, Georgia Crinetics Study Site, Lexington, Kentucky Crinetics Study Site, Metairie, Louisiana Crinetics Study Site, Grand Rapids, Michigan Crinetics Study Site, Philadelphia, Pennsylvania Crinetics Study Site, Austin, Texas Crinetics Study Site, Houston, Texas Crinetics Study Site, Irving, Texas Crinetics Study Site, Salt Lake City, Utah Crinetics Study Site, Charlottesville, Virginia Crinetics Study Site, Fairfax, Virginia Spain
Crinetics Study Site, Barcelona Crinetics Study Site, Barcelona Crinetics Study Site, Madrid Crinetics Study Site, Madrid